Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-20

Clinical Trial Update: A Study of Cizutamig for Patients With Ulcerative Colitis [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 clinical trial of Cizutamig for ulcerative colitis is listed, with recruitment not yet started. Sponsor is Ruijin Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cizutamig

Snippet

Sponsor: Ruijin Hospital | Conditions: Ulcerative Colitis (UC) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING